高分子量激肽原(HMWK)重组蛋白
Recombinant High Molecular Weight Kininogen (HMWK)
Williams-Fitzgerald-Flaujeac Factor; Fitzgerald Factor; HMWK-Kallikrein Factor
- 编号RPB805Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量14.3kDa
- 实际分子量15kDa(差异分析请参阅说明书)
- 片段与标签Arg58~Leu176 (Accession # P01042) with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点6.28
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPB805Hu01 | 高分子量激肽原(HMWK)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB805Hu02 | 高分子量激肽原(HMWK)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB805Hu01 | 高分子量激肽原(HMWK)多克隆抗体 | WB; IHC; ICC; IP. |
PAB805Hu02 | 高分子量激肽原(HMWK)多克隆抗体 | WB; IHC; ICC; IP. |
LAB805Hu71 | 高分子量激肽原(HMWK)多克隆抗体(生物素标记) | WB; IHC; ICC. |
SEB805Hu | 高分子量激肽原(HMWK)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB805Hu | 高分子量激肽原(HMWK)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB805Hu | 高分子量激肽原(HMWK)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Thromb Res | Factor XII–mediated contact activation related to poor prognosis in disseminated intravascular coagulation [PubMed: 26706311] |
Thrombosis Research | Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coaCavia (Guinea pig )lation [Pubmed:26706311] |
european journal of endocrinology | Contact system activation and high thrombin generation in hyperthyroidism. [pubmed:28137735] |
J Thromb Thrombolysis | Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors [Pubmed:34993714] |
留言咨询